Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- GOOS +13.8%, ZTO +11.3%, ATS +10.7%, LSPD +7%, WMT +5%, CGEM +4.7%, JD +4%, GRAB +3.9%, CPA +3.5%, SGML +3.3%, CSCO +3.1%, DDS +2%, KARO +1.4%, WMS +1.3%
Other news:
- ASTS +31% (enters into commercial agreement with AT&T; also reports earnings)
- SBOW +11.6% (SilverBow Resources confirms it will be acquired by Crescent Energy (CRGY))
- ARVN +11.4% (Arvinas and Pfizer (PFE) announce updated clinical data from phase 1b Trial of vepdegestrant in combination with palbociclib IBRANCE)
- CB +8.3% (Berkshire Hathaway discloses new large position in CB)
- GLPG +3.1% (announces collaboration to accelerate CAR-T manufacturing network)
- OABI +2.6% (presents xPloration data)
- DO +2.3% (DO extends contract extension with OXY unit)
- IONS +1.9% (announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome)
- WERN +1.4% (authorizes new 5 mln share repurchase program)
- PANW +1.3% (PANW and IBM partnering to deliver AI-powered security outcomes)
- EG +1.3% (increases dividend)
- NIO +1.3% (new models unveiled)
- TNL +1.2% (increases stock repurchase authorization by $500 mln)
- MOR +1% (Novartis (NVS) meets all tender offer conditions to acquire MorphoSys AG for EUR 68 per share in cash)